Symrise : Strong Q3 : 13.6% (cons 10.9%) org sales growth; sales growth outlook raised to '>10%' (>7%) vs 9.4% cons, suggests 4% cons upside at EBITDA
>Strong 13.6% organic sales growth in Q3 - Symrise reported strong group sales of € 1,233m in Q3 2022, 4% ahead of consensus of €1,183m (ODDO BHF €1,139m) and up 26.4% y-o-y. Organic growth of 13.6% y-o-y was strong and ahead of consensus of 10.9% (ODDO BHF 9.5%) and compares to the Q2 2022 level of 12.0% (Q3 21: 8.3%). FX and portfolio effects contributed 8.1pp and 4.8pp to y-o-y growth.Much better T,N&H sales growth in Q3 with 18% - Taste, Nutrition...Symrise AG develops, produces, and sells fragrances and flavors as well as active ingredients for the cosmetics industry. Co. operates in two main business segments: The Scent & Care segment, which develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances; and The Flavor & Nutrition segment, which develops, produces and sells flavors that are used by customers in the production of food products (savory and sweet food products as well as dairy products) and beverages.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.